跳至主要内容
临床试验/JPRN-UMIN000004526
JPRN-UMIN000004526已完成未知

Transcatheter arterial infusion chemotherapy using miriplatin in patients with advanced hepatocellular carcinoma: Prospective randomized study, Lip-TAI vs. Lip+DSM-TAI - TAI using miriplatin: Lip-TAI vs. Lip+DSM-TAI

Department of Gastroenterology and Hepatology, Yamaguchi Univercity Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2010年11月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Parients with severe complicating disease except chronic hepatitis or liver cirrhosis. 2) Patients with active double cancer. 3) The patient with the anamnesis of the hypersensitivity. 4) A pregnant woman, or woman who may pregnant and who are nursing. 5) Patients who were disqualified by doctor in attendance.

研究者

发起方
Department of Gastroenterology and Hepatology, Yamaguchi Univercity Graduate School of Medicine

相似试验